1-2 of 2
Ebba Sohlberg, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Efficient Scale-up and Pre-Clinical Evaluation of NKG2C+ Adaptive NK Cell Expansion for Therapy Against High-Risk AML/MDS

Ebba Sohlberg, PhD, Alvaro Haroun-Izquierdo, Andreas T Björklund, MD PhD MSc, Sarah Cooley, MD, Merete Thune Wiiger, Msc, Jodie Peter Goodridge, PhD, Hanna Julie Hoel, Aline Pfefferle, Michael Chrobook, Veronika Kremer, Eva Hellström-Lindberg, MD PhD, Eivind Heggernes Ask, Blomberg Pontus, Bahram Valamehr, PhD, Karolin Guldevall, Hanna van Ooijen, Bjorn Onfelt, Evren Alici, MD PhD, Hans-Gustaf Ljunggren, Jeffrey S. Miller, MD, Karl-Johan Malmberg, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 195.
https://doi.org/10.1182/blood-2018-195
Published: 2018
Journal Articles

Complete Remission and Signs of Immunoediting Following Haploidentical NK Cell Therapy in Refractory High-Risk MDS and AML Ell Therapy in Refractory High-Risk MDS and AML

Andreas T Björklund, MD PhD MSc, Mattias Carlsten, MD PhD, Ebba Sohlberg, PhD, Trevor Clancy, Lisa Liu, Mohsen Karimi, PhD, Sarah Cooley, MD, Jeffrey S. Miller, MD, Emma Watz, Björn Engelbrekt Wahlin, Marzia Palma, MD PhD, Lotta Hansson, Per Ljungman, Eva Hellstrom-Lindberg, MD PhD, Hans-Gustaf Ljunggren, Karl-Johan Malmberg, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4458.
https://doi.org/10.1182/blood.V130.Suppl_1.4458.4458
Published: 2017